Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Annals of Internal Medicine|May 2, 2007
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trialWilliam J Sandborn, Paul Rutgeerts, Robert Enns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 30, 2018
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc AnalysisJean-Frédéric Colombel, Omoniyi J Adedokun, Christopher Gasink, et al.
Human Molecular Genetics|October 2, 2002
Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkageRichard H Duerr, M Michael Barmada, Leilei Zhang, et al.
Gastrointestinal Endoscopy|February 28, 2006
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseasePaul Rutgeerts, Robert H Diamond, Mohan Bala, et al.
European Urology|December 12, 2018
Inflammatory Bowel Disease and the Risk of Prostate CancerJacob A Burns, Adam B Weiner, William J Catalona, et al.
Inflammatory Bowel Diseases|May 11, 2011
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenesJoel R Pekow, Urszula Dougherty, Reba Mustafi, et al.
Gastroenterology|March 23, 2021
Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal CancerTriet M Bui, Veronika Butin-Israeli, Hannah L Wiesolek, et al.
Gastroenterology|February 8, 2018
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's DiseaseOmoniyi J Adedokun, Zhenhua Xu, Christopher Gasink, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Endoscopic Response to Subcutaneous Infliximab by Disease Location: A Post Hoc Analysis of the LIBERTY-CD StudyBruce E Sands, Stefan Schreiber, Marla C Dubinsky, et al.
The New England Journal of Medicine|May 5, 2016
Ozanimod Induction and Maintenance Treatment for Ulcerative ColitisWilliam J Sandborn, Brian G Feagan, Douglas C Wolf, et al.
Pageof 22